Human Genome Epidemiology Literature Finder
Cancer
|
Records 1 - 30 (of 9289 Records) |
| Query Trace: Lung Cancer[original query] |
|---|
| EGFR Exon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment? Anticancer research 2024 12 45 (1): 335-340. Giuseppina Improta, Giulia Vita, Alfredo Tartarone, Giovanni Calice, Ludmila Carmen Omer, Angela Zu |
| Association of RFC G80A Polymorphism with Lung Cancer Susceptibility in a Hypertensive Population: A Nested Case-Control Study. The Journal of nutrition 2024 12 . Qiangqiang He, Yaping Wei, Hehao Zhu, Yun Song, Ping Chen, Qing Dong, Hai Ma, Binyan Wang, Yan Zhang, Jianping Li, Yong Huo, Hanping Shi, Yuhan Do |
| Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA. Investigational new drugs 2025 1 . Yoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, Shun-Ichi Isa, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Koji Yamazaki, Masahiro Shimada, Masahiko Ando, Yasuhiro K |
| Patients with non?small cell lung cancer with the exon 21 L858R mutation: From distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (Review). Oncology letters 2025 1 29 (3): 109. Jia-Yu Liu, Shou-Zheng Wang, Han-Qi Yuan, Jun-Ling Li, Pu-Yuan Xi |
| Comparative analysis of EGFR mutations in circulating tumor DNA and primary tumor tissues from lung cancer patients using BEAMing PCR. Scientific reports 2025 1 15 (1): 1252. Duhita Mirikar, Nandini Banerjee, Kumar Prabhash, Rajiv Kumar Kaushal, Vanita Naronha, C S Pramesh, George Karimundackal, Amit Joshi, Swapnil Rane, Ranjan Bas |
| Risk factors for brain metastasis in lung cancer: an umbrella review of systematic reviews and meta-analyses. BMJ open 2025 1 15 (1): e087181. Xinliang Wan, Handan Mo, Jixin Chen, Qichun Zhou, Shenghong Qiu, Yongchun Zou, Wanyin Wu, Qing Tang, Sumei Wa |
| Prevalence of EGFR Mutations in Patients With Resected Stage I to III Nonsquamous Non-Small Cell Lung Cancer: Results of India Cohort. JCO global oncology 2025 1 11 e2400353. Ullas Batra, Kumar Prabhash, Vanita Noronha, Ramakant Deshpande, Sachin Khurana, Gull Mohammad Bhat, Rajesh Mistry, Vivek Agarwala, Sajjan Rajpurohit, Bhavesh Poladia, Mansi Sharma, Saquib Zaffar Band |
| The Association Between Body Composition, Overall Survival, Treatment Decisions, and Patient-Reported Outcomes in Metastatic Non-Small-Cell Lung Cancer. Cancer medicine 2025 1 14 (1): e70534. Adriana M Coletta, Hyejung Lee, Sonam Puri, Sinead Culleton, Matthew F Covington, Jeffrey T Yap, Kelsey E Maslana, Benjamin Haaland, Wallace Akerl |
| Analysis of the benefit of anti-PD-1 monotherapy according to NGS-diagnosed genetic alterations in patients with non-small cell lung cancer. Exploration of targeted anti-tumor therapy 2025 1 5 (6): 1435-1449. Hortense De Saint Basile, Reza Elaidi, Zineb Maaradji, Hélène Blons, Rym BenDhiab, Laure Gibault, Elizabeth Fab |
| The role of APOE gene polymorphisms in lung adenocarcinoma susceptibility and lipid profile. Frontiers in immunology 2025 1 15 1522761. Huanhuan Bi, Dunqiang Ren, Ye Wang, Hongmei Wang, Chunling Zha |
| Glecirasib in KRAS-mutated nonsmall-cell lung cancer: a phase 2b trial. Nature medicine 2025 1 . Yuankai Shi, Jian Fang, Ligang Xing, Yu Yao, Jian Zhang, Lian Liu, Yongsheng Wang, Changlu Hu, Jianping Xiong, Zhihua Liu, Runxiang Yang, Zhen Wang, Enfeng Zhao, Mengzhao Wang, Yanqiu Zhao, Kejing Tang, Zhihua Li, Zhengbo Song, Yongsheng Li, Wu Zhuang, Bo Jin, Ying Cheng, Yanping Hu, Yanhong Gu, Lin Wu, Rui Ma, Qitao Yu, Yan Yu, Jun Zhao, Hui Zhao, Dongqing Lv, Yanhong Shang, Puyuan Xing, Jin Zhou, Xingya Li, Zhe Liu, Zhaoxia Dai, Guohao Xia, Xueqin Chen, Yi Ba, Chunmei Bai, Qingshan Li, Guangyu An, Weiguo Hu, Yinxiang Wang, Andrea Wang-Gillam, Yuli Ding, Qiao Li, Zhiyue R |
| A novel UBA1 gene mutation in a patient with infantile respiratory distress syndrome. Human genome variation 2025 1 12 (1): 2. Masafumi Miyata, Arisa Kojima, Yuri Kawai, Hidetoshi Uchida, Hiroko Boda, Naoko Ishihara, Hidehito Inagaki, Tetsushi Yoshikawa, Hiroki Kurahas |
| Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases. Heliyon 2025 1 10 (24): e40703. Liqun Li, Zhe Huang, Yangqian Chen, Hongzhi Ma, Xiaoquan Chen, Huan Yan, Haoyue Qin, Yuda Zhang, Xing Zhang, Wenjuan Jiang, Zhan Wang, Lin Zhang, Fanxu Zeng, Zhiguo Zhou, Xingxiang Pu, Nong Yang, Liang Zeng, Yongchang Zha |
| Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial. The Lancet. Oncology 2025 1 26 (1): 74-84. Yanjun Xu, Kaiyan Chen, Yujin Xu, Hui Li, Zhiyu Huang, Hongyang Lu, Dingzhi Huang, Sizhe Yu, Na Han, Lei Gong, Jing Qin, Jun Chen, Fajun Xie, Wei Hong, Xiao Lin, Fengzhuo Cheng, Xiaojie Luo, Yun F |
| Identification of immune characteristics of two lung adenocarcinoma subtypes based on immune- and pyroptosis-related genes to improve immunotherapy. Bulletin du cancer 2025 1 . Yifan Tie, Jinzhi |
| Amivantamab Plus Lazertinib in Patients With EGFR-mutant Non-small Cell Lung Cancer (NSCLC) After Progression on Osimertinib and Platinum-based Chemotherapy: Results From CHRYSALIS-2 Cohort A. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2025 1 . Benjamin Besse, Koichi Goto, Yongsheng Wang, Se-Hoon Lee, Melina E Marmarelis, Yuichiro Ohe, Reyes Bernabe Caro, Dong-Wan Kim, Jong-Seok Lee, Sophie Cousin, Eiki Ichihara, Yongsheng Li, Luis Paz-Ares, Akira Ono, Rachel E Sanborn, Naohiro Watanabe, Maria Jose de Miguel, Carole Helissey, Catherine A Shu, Alexander I Spira, Pascale Tomasini, James Chih-Hsin Yang, Yiping Zhang, Enriqueta Felip, Frank Griesinger, Saiama N Waqar, Antonio Calles, Joel W Neal, Christina S Baik, Pasi A Jänne, S Martin Shreeve, Joshua C Curtin, Bharvin Patel, Michael Gormley, Xuesong Lyu, Jun Chen, Pei-Ling Chu, Janine Mahoney, Leonardo Trani, Joshua M Bauml, Meena Thayu, Roland E Knoblauch, Byoung Chul C |
| Prognostic factors in patients with bone metastasis of lung cancer after immune checkpoint inhibitors: A retrospective study. World journal of orthopedics 2025 1 15 (12): 1155-1163. Yuki Ishibashi, Hiroshi Kobayashi, Toshihiko Ando, Kouichi Okajima, Takahiro Oki, Yusuke Tsuda, Yusuke Shinoda, Ryoko Sawada, Sakae Tana |
| Comprehensive analysis of genomic alterations and novel prognostic biomarkers, and establishment of prediction models of metastasis in metastatic non-small cell lung cancer. Journal of Cancer 2025 1 16 (1): 339-350. Kangwei Wang, Meifeng Ye, Zexun Mo, Xiaomei Huang, Yujun Li, Shuquan W |
| Efficacy and safety of chemotherapy combined with iodine-125 seed brachytherapy for intermediate and advanced oncogenic driver gene-negative non-small cell lung cancer. Brachytherapy 2025 1 24 (1): 92-102. Meng-Hua Xia, Kai-Cai Liu, Wei Zhao, Yi-Zhuang Cheng, Liang-Ping Shi, Li-Qin Bi, Xue-Ran Guo, Meng-Xia Zhang, Wei-Fu |
| Construction of a cuproptosis-tricarboxylic acid cycle-associated lncRNA model to predict the prognosis of non-small cell lung cancer. Translational cancer research 2025 1 13 (12): 6807-6824. Xiang Li, Yunlong Zhao, Shengjie Wei, Yuqing Dai, Chun |
| Comparison of tissue-based and plasma-based testing for EGFR mutation in non-small cell lung cancer patients. Journal of pathology and translational medicine 2025 1 59 (1): 60-67. Yoon Kyung Kang, Dong Hoon Shin, Joon Young Park, Chung Su Hwang, Hyun Jung Lee, Jung Hee Lee, Jee Yeon Kim, JooYoung |
| A Drug-Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non-Small Cell Lung Cancer. Clinical pharmacology in drug development 2025 1 . Michael J Hanley, Steven Zhang, Nick Pavlakis, Ross A Soo, Anthonie J van der Wekken, Vinod Ganju, Adela Piña, Qi Dong, Neeraj Gup |
| Non small cell lung cancer with SMARCA4 deficiency harboring rare EGFR mutations exhibited significant tumor response when treated with afatinib: a case report. Frontiers of medicine 2025 1 . Xiaotong Qiu, Liangkun You, Chongwei Wang, Jin She |
| Real-World Incidence of Anaplastic Lymphoma Kinase alterations in Hispanics with Non-Small Cell Lung Cancer at a Large Academic Institution in Los Angeles. Cancer research communications 2025 1 . Darin Poei, Sana Ali, Jacob S Thomas, Jorge J Nieva, Robert C H |
| TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate. Genome medicine 2025 1 17 (1): 3. Paula Rofes, Carmen Castillo-Manzano, Mireia Menéndez, Álex Teulé, Sílvia Iglesias, Elisabet Munté, Mireia Ramos-Muntada, Carolina Gómez, Eva Tornero, Esther Darder, Eva Montes, Laura Valle, Gabriel Capellá, Marta Pineda, Joan Brunet, Lidia Feliubadaló, Jesús Del Valle, Conxi Láza |
| Brief report: Impact of consolidation durvalumab on unresectable non-small lung cancer with driver mutations. Cancer treatment and research communications 2025 1 42 100863. Jason C S Ho, K M Cheu |
| Impact of co-mutations and transcriptional signatures in non-small cell lung cancer patients treated with adagrasib in the KRYSTAL-1 trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2025 1 . Marcelo V Negrao, Alvaro G Paula, David Molkentine, Laura Hover, Monique Nilsson, Natalie Vokes, Lars Engstrom, Andrew Calinisan, David M Briere, Laura Waters, Jill Hallin, Lixia Diao, Mehmet Altan, George R Blumenschein, Ferdinandos Skoulidis, Jing Wang, Scott E Kopetz, David S Hong, Don L Gibbons, Peter Olson, James G Christensen, John V Heyma |
| RET-AREAL: a multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs. Cancer letters 2025 1 217455. Xinjun Tang, Jie Hu, Renhua Guo, Yina Wang, Yu Yao, Liang Zeng, Haitao Wang, Haibo Shen, Jun Chen, Weina Huang, Lihua Liu, Ming Su, Zhuang Yu, Weidong Mao, Jinliang Wang, Haitao Tao, Guilan Dong, Chang Cai, Yupeng Xie, Tao Qu, Yan Zhang, Wei Shen, Jing Cao, Xin Cai, Wencui Kong, Xiaoxue Li, Fei Lia |
| Enhanced detection of actionable mutations in NSCLC through pleural effusion cell-free DNA sequencing: A prospective study. European journal of cancer (Oxford, England : 1990) 2025 1 217 115224. Hsin-Yi Wang, Wei-Yu Liao, Chao-Chi Ho, Shang-Gin Wu, Ching-Yao Yang, Chia-Lin Hsu, Yen-Ting Lin, James Chih-Hsin Yang, Jin-Yuan Sh |
| Ethnic disparities in survival and progression among EGFR-mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: a systematic review and meta-analysis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2025 1 . Francisco Cezar Aquino de Moraes, Anna Luíza Soares de Oliveira Rodrigues, Eric Pasqualotto, Jessica Fernanda Cassemiro, Jhonny Wilson Limachi Choque, Rommel Mario Rodríguez Burba |
- Page last reviewed:Feb 1, 2024
- Content source: